Rothschild Investment LLC Guardant Health, Inc. Transaction History
Rothschild Investment LLC
- $1.6 Trillion
- Q2 2025
A detailed history of Rothschild Investment LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 245 shares of GH stock, worth $13,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245
Previous 220
11.36%
Holding current value
$13,499
Previous $9.37 Million
36.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GH
# of Institutions
404Shares Held
125MCall Options Held
1.47MPut Options Held
2.39M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$300 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$284 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...